Publications

The following is a table of publications related to mannitol and its use as a bronchial challenge agent. This list is updated regularly, with publications appearing in date order.

Mannitol as a Bronchial Challenge Test

Authors Title Reference
Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156: 758-765.
Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med, 1998: 158:1120-1126.
Subbarao P, Brannan JD, Ho B, Anderson SD, Chan H-K, Coates AL. Inhaled mannitol identifies methacholine-responsive children with current asthma. Pediatr Pulmonol 2000; 29:291-298.
Brannan JD, Anderson SD, Freed R, Leuppi JD, Koskela H, Chan H-K. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. Am J Respir Crit Care Med 2000; 161; 2096-2099.
Koskela H, Di Sciascio M, Anderson SD, Andersson M, Chan H-K, Gadalla S, Katelaris C. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement. Clin Exp Allergy 2000; 30(11):1628-1636.
Leuppi JD. Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, Koskela H, Brannan JD, Freed R, Andersson M, Chan H-K, Woolcock AJ. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163:406-412.
Högman M, Lúdviksdóttir D, Anderson SD, George S, Hakansson L, Chan HK, Meriläinen,P, Hedenström H. Inhaled mannitol shifts exhaled nitric oxide in opposite directions in asthmatic and healthy subjects. Respiration Physiology 2001; 124:141-150.
Brannan JD, Anderson SD, Gomes K, King GG, Chan H-K, Seale JP. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 2001; 163: 1420-1425.
Leuppi JD. Salome CM, Jenkins CR, Koskela H, Anderson SD, Andersson M, Chan H-K, Woolcock AJ. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J 2001; 18(3):444-450.
Brannan JD, Koskela H, Anderson SD, Chan H-K. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002; 7(1):37-44.
Leuppi JD, Brannan JD, Anderson SD. Bronchial provocation tests: The rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Medical Weekly 2002; 132:151-158.
Anderson SD, Brannan JD, Chan HK. Use of aerosols for bronchial provocation testing in the laboratory: Where we have been and where we are going. J Aerosol Med 2002;15(3):313-324.
Holzer K, Anderson SD, Douglass J. Exercise in Elite Summer Athletes: challenges for diagnosis. J Allergy Clin Immunol 2002; 110: 374-380.
Holzer K, Anderson SD, Chan H-K, Douglass J. Mannitol as a challenge to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003; 167: 534-537.
Anderson SD, Brannan JD. Methods for 'indirect' challenge tests including exercise, eucapnic voluntary hyperpnea and hypertonic aerosols. Clin Rev Allergy Immunol 2003; 24: 27-54.
Currie GP, Haggart K, Lee DKC, Fowler SJ, Wilson AM, Brannan JD, Anderson SD, Lipworth BJ. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy 2003; 33:783-788.
Currie GP, Haggart K, Brannan JD, Lee DKC, Anderson SD, Lipworth BJ. Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate. Allergy 2003 58:762-766
Koskela HO, Hyvärinen L, Brannan JD, Chan H-K, Anderson SD. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 2003; 124(4):1341-1349.
Koskela H.O; Hyvärinen L; Brannan J.D; Chan H.K; Anderson S.D Responsiveness to Three Bronchial Provocation Tests in Patients With Asthma Chest 2003; 124:2171-2177
Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003; 22(3):491-496
Lee DK, Haggart K, Currie GP, Anderson SD, Lipworth BJ. The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis. Br J Clin Pharmacol 2003; 55(6):639-642.
Brannan JD Inhaled Mannitol ; A new Bronchial Provocation Test to assess the presence and severity of asthma. RT International, Fall 2003: 29-3142.
Barben J, Roberts, Chew N, Carlin J.B, Robertson C.F Repeatability of Bronchial Responsiveness to Mannitol Dry Powder in Children With Asthma Pediatric Pulmonology 36:490-494 (2003)
Joos G.F (Chairman), O'Connor B (Co-Chairman), Anderson S.D, Chung F, Cockcroft D.W, Dahlén B, DiMaria G, Foresi A, Hargreave F.E, Holgate S.T, Inman M, Lötvall J, Magnussen H, Polosa R, Postma D.S, Riedler J. ERS Task Force Report: Indirect airway challenges Eur Respir J 2003; 21: 1050-1068
Brannan JD, Anderson SD, Perry CP, Kippelen P, Freed R, Holzer K, Sue-Chu M Bronchial Provocation Tests using a Dry Powder of Mannitol in Asthmatic and Healthy Subjects with Normal Spirometry VIIth IOC World Congress on Sports Science Athens, Greece October 2003
Gulliksson M, Brannan J.D, Anderson S.D, Seale P.J, Delin I, Kumlin M. Inhibition of the airway response to mannitol with either eformoterol or sodium cromoglycate (SCG) does not alter leukotriene release in asthmatic subjects Eur Resp J, 2004; 24: 443s ;P2735
Currie G.P, Jackson C.M, Lipworth B.J Does Bronchial Hyperresponsiveness in Asthma Matter? J of Asthma Vol. 41, 3, pp. 247-258, 2004
Koskela H.O, Hyvärinen L,Brannan J.D,Chan H-K, Anderson S.D. Coughing During Mannitol Challenge Is Associated With Asthma Chest 2004; 125:1985-1992
Barben J, Riedler J Measurement of Bronchial Responsiveness in Children Paed Pulm Function Testing. Prog Respir Res. Basel, Karger, 2005, vol 33, pp 125-136
Leuppi J.D, Tandjung R, Anderson S.D, Stolz M.H, Brutsche M.H, Bingisser R, Perruchoud A.P, Surber C, Knoblauch A, Andersson M, Greiff L, Chan H-K, Tamm M Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept Pulmonary Pharmacology & Therapeutics 18 (2005) 83-88
Anderson S.D, Brannan J.D, Koskela H, Freed-Martens R, Leuppi J.D, Holzer K, Lipworth B, Currie K, Sue-Chu M, Perry C.P. Provoking Dose Of Mannitol To Assess Airway Hyperresponsiveness In Asthma: A Retrospective Analysis Abstract No: 1460 AAAAI ASM 2005 (Poster)
Anderson S.D Theory and Rationale for bronchial provocation studies in asthma Session 2714: AAAAI San Antonio Texas 2005 (Pres.)
Anderson S.D Bronchoprovocation Challenges: The How To's Session 4701: AAAAI San Antonio Texas 2005 (Pres.)
Freed-Martens R, Anderson S.D, Brannan J.D, Aridol study group Effect of treatment on recovery of FEV1 to baseline after a mannitol challenge: a phase 3 study Australian New Zealand Soc Resp Sci ASM 2005 Abst.
Brannan J.D, Anderson S.D, Freed-Martens R.H, and The Aridol Study Group. Bronchial provocation using inhaled mannitol - a phase 3 trial of adult asthmatics and non-asthmatics ATS 2005 Abstract #953009
Anderson S.D, Brannan J.D, Freed-Martens R.H, and The Aridol Study Group. Bronchial provocation using inhaled mannitol - a phase 3 trial of paediatric asthmatics and non-asthmatics ATS 2005 Abstract #955218
Anderson S.D, Brannan J.D, Koskela H, Leuppi J.D Monitoring Airway Hyperresponsiveness: Indirect Stimuli-Exercise, Hypertonic Saline, Mannitol, and AMP Monitoring Asthma ed. Gibson PG; Taylor and Francis Group, Boca Raton USA
Koskela H, Martens R, Brannan JD, Anderson SD, Leuppi JD, Chan H-K. Dissociation in the effect of nedocromil on mannitol-induced cough or bronchoconstriction in asthmatic subjects Respirology (2005) 10, 442-448
Anderson SD, Bruscasco V, Haahtela T, Popov T. In: Diagnosis and Treatment of Exercise-Related Asthma, Respiratory and Allergic Disorders in Sports. Criteria for diagnosis of asthma, EIB and AHR for athletes: lessons from the Olympic Games Carlsen K-H, Delgado L, Del Giacco S,Eds. Eur Respir Mon: European Respiratory Society, 2005; 10(33); Chpt 6
Carlson KH; taskforce on recognising and diagnosing exercise related asthma, respiratory and allergic disorders in sport. Evidence based recommendations for the diagnosis of exercise induced asthma in athletes. Carlsen K-H, Delgado L, Del Giacco S, Eds. Eur Respir Mon: European Respiratory Society, 2005;10(33);Chpt 10
Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B and the Aridol Study Group The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline Respiratory Research 2005, 6:144
Anderson SD Best indicators of asthma control; Asthma biomarkers including spirometry AAAI 2006, Session 5533 workshop presentation
Brannan J.D, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Eur Respir J 2006; 27: 944-950
Muñoz PA, Manrique H.A, Drakulovic MB, Gómez FP, Burgos F, Valera JL, Roca J, Picado C. & Rodriguez-Roisin R. Pulmonary Gas Exchange Response to Exercise and Mannitol Challenges in Exercise-Induced Asthma Patients ATS 2006, Poster
Holzer K, Douglass JA Exercise induced bronchoconstriction in elite athletes: measuring the fall Thorax 2006;61;94-96
Menzies D, Nair A, Lipworth BJ. Non-Invasive Measurement of Airway Inflammation in Asthma Journal of Asthma, 43:407-415, 2006
Porsbjerg C, Rasmussen L, Thomsen SF, Brannan JD, Anderson SD, Backer V. Response to mannitol in asymptomatic subjects with airway hyper-responsiveness to methacholine Clin Exp Allergy. 2007 Jan;37(1):22-8.
Stolz D, Anderson SD, Gysina C., Miedingera D, Surber C, Tamm M, Leuppi JD. Airway reactivity to inhaled mannitol in cigarette smokers: A longitudinal study Respir Med (2007), doi:10.1016/j.rmed.2007.01.008
Meidinger D, Chhajed PN, Stolz, D, Gysin C, Wanzenried A-B., Schindler C, Suber C, Bucher H.C.,Tamm, M, Leuppi JD. Diagnostic tests for asthma in fire fighters Eur Respir J. 2007 May 30;
Brannan JD, Koskela H and Anderson SD Monitoring asthma therapy using indirect bronchial provocation tests The Clinical Respiratory Journal, 1: 3-15, 2007
Porsbjerg C, Brannan JD, Anderson SD, and Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients Clinical and Experimental Allergy, 38, 43-50, 2007
Daviskas E, Anderson SD, Brannan JD, Chan H-K, Eberl S, Bautovich G. Inhalation of dry powder mannitol increases mucociliary clearance. Eur Resp J, 1997; 10: 2449-2454.
Daviskas E, Anderson SD, Eberl S, Chan H-K, Bautovich G. Inhalation of dry powder mannitol improves mucociliary clearance in patients with bronchiectasis. Amer J Respir Crit Care Med 1999;159:1843-1848.
Robinson M, Daviskas E, Eberl S, Baker J, Anderson SD, Bye PTP. The effects of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur Respir J 1999; 14(3):678-685.
Daviskas E, Robinson M, Anderson SD, Bye PTP. [Editor: Salathe M.] The effect of dry powder mannitol on the clearance of mucus. In: Cilia and Mucus. Marcel Dekker, New York 2001 pp 361-369.
Daviskas E, Anderson SD, Eberl S, Chan H-K, Young IH. The 24-hr effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest 2001; 119: 414-421.
Daviskas E, Robinson M, Anderson SD, Bye PTP. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. J Aerosol Med 2002; 3: 331-341.
Daviskas E, Anderson SD, Eberl S, Chan H-K, Young IH, Sealez J.P. Effects of terbutaline in combination with mannitol on mucociliary clearance Eur Resp J, 2002; 20: 1423-1429
Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis (Cochrane Review) The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
Goldman M.D, Daviskas E, Turton J.A, Anderson S.D. Inhaled mannitol improves lung function assessed by forced oscillation in a placebo controlled trial in patients with bronchiectasis Eur Resp J, 2004; 24: 470s-471s ;P2943 Presentation also included on CD ROM
Daviskas E, Turton J.A, Anderson S.D, Young I.H, Lassig A, Charlton B. A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis Eur Resp J, 2004; 24: 707s ;P4338 Presentation also included on CD ROM
Daviskas E, Anderson S.D, Gomes K, Briffa P, Cochrane B, Chan H-K, Young I.H, Rubin B.K. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum Respirology, 2005; 10: 46-56
Daviskas E, Anderson S.D Hyperosmolar Agents and Clearance of Mucus in the Diseased Airway J Aerosol Medicine Volume 19, Number 1, 2006. 100-109
Charlton B, Lassig A Inhaled dry powder mannitol (Bronchitol) improves FEV1 in cystic fibrosis Abstract TO20 Respirology 2006, 11, (suppl.2): p A11
Wills P, Greenstone M Inhaled hyperosmolar agents for bronchiectasis (Review) The Cochrane Library 2006, Issue 2
Charlton B. Inhaled dry powder mannitol treatment in CF ATS presentation 2006
Will P Inhaled mannitol in CF Expert Opin. Investig. Drugs 2007, 16(7): 1121-1126
Daviskas E, Anderson S.D, Young I.H. Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion Respirology (2007): 1440-1843
ten Hacken NHT, Wijkstra PJ, Kerstjens HAM Treatment of bronchiectasis in adults BMJ 2007;335:1089-93
Daviskas E, Anderson S.D, Eberl S, Young I.H. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis Eur Respir J 2008; 31: 765-772
 
dms stats recording image